Literature DB >> 11890215

The B-type natriuretic peptide assay: a rapid test for heart failure.

W Frank Peacock1.   

Abstract

The B-type or brain natriuretic peptide (BNP) assay, a 15-minute bedside blood test, is highly sensitive and fairly specific for diagnosing heart failure and is useful in evaluating suspected heart failure in outpatients and in emergency care. Other uses include screening for left ventricular dysfunction and predicting outcome in patients with an established diagnosis of heart failure or myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11890215     DOI： 10.3949/ccjm.69.3.243

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  5 in total

1.  Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.

Authors:  L Schwachtgen; M Herrmann; T Georg; P Schwarz; N Marx; A Lindinger
Journal:  Z Kardiol       Date:  2005-06

2.  Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction.

Authors:  Simona L Bar; Naser Sayeh; Andrew P Ignaszewski
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

3.  Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?

Authors:  Khulan Khurelsukh; Yun-Hyeon Kim; Hyun Ju Seon; Jang Hyun Song; Seo Yeon Park; Sung Min Moon; Soo Hyun Kim; Doo Sun Sim; Youngkeun Ahn
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

4.  Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis.

Authors:  Simona L Bar; Elizabeth Swiggum; Lynn Straatman; Andrew Ignaszewski
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

Review 5.  Natriuretic peptides in cardiovascular diseases.

Authors:  Mariusz Piechota; Maciej Banach; Anna Jacoń; Jacek Rysz
Journal:  Cell Mol Biol Lett       Date:  2008-04-10       Impact factor: 5.787
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.